https://sentinelinitiative.org/methods-data-tools/methods/covid-19-pregnancy-study-implementation
COVID-19 Pregnancy Study Implementation
Methods, Data, & Tools
02/24/2021
Methods, Data, & Tools
02/24/2021
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/follow-time-guselkumab-risankizumab-and-tildrakizumab-users
Follow-Up Time for Guselkumab, Risankizumab, and Tildrakizumab Users with Plaque Psoriasis: First Descriptive Analysis
Modular Programs
03/30/2021
Modular Programs
03/30/2021
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/ebglyss-lebrikizumab
Assessment of ARIA Sufficiency: Ebglyss (lebrikizumab)
Sufficiency Assessments
04/08/2021
Sufficiency Assessments
04/08/2021
https://sentinelinitiative.org/methods-data-tools/methods/improving-probabilistic-phenotyping-incident-outcomes-through-enhanced
Improving Probabilistic Phenotyping of Incident Outcomes through Enhanced Ascertainment with Natural Language Processing
Methods, Data, & Tools
05/20/2021
Methods, Data, & Tools
05/20/2021
https://sentinelinitiative.org/methods-data-tools/methods/making-medicaid-data-more-accessible-through-common-data-models-and-fhir
Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs
Methods, Data, & Tools
09/24/2021
Methods, Data, & Tools
09/24/2021
https://sentinelinitiative.org/news-events/publications-presentations/utilization-post-exposure-prophylaxis-prevent-lyme-disease
Utilization of Post-Exposure Prophylaxis to Prevent Lyme Disease in a Large US Healthcare Database
Publications and Presentations
09/29/2021
Publications and Presentations
09/29/2021
https://sentinelinitiative.org/news-events/publications-presentations/evaluating-confounding-control-estimations-influenza-0
Evaluating Confounding Control in Estimations of Influenza Antiviral Effectiveness in Electronic Health Plan Data
Publications and Presentations
02/02/2022
Publications and Presentations
02/02/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/n-nitrosodimethylamine-ndma-contaminated-and-non-ndma
N‐nitrosodimethylamine (NDMA)‐Contaminated and Non‐NDMA‐Contaminated Valsartan Use: A Descriptive Analysis
Analyses
02/18/2022
Analyses
02/18/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/incidence-and-prevalence-n-nitrosodimethylamine-ndma-and-n
Incidence and Prevalence of N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Contaminated Valsartan Use: A Descriptive Analysis
Analyses
03/01/2022
Analyses
03/01/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/incident-and-prevalent-use-loop-diuretics-descriptive
Incident and Prevalent Use of Loop Diuretics: A Descriptive Analysis
Analyses
03/23/2022
Analyses
03/23/2022
https://sentinelinitiative.org/engage-sentinel/quarterly-newsletter
Quarterly Newsletter
Spotlight
03/24/2022
Spotlight
03/24/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/counts-and-characteristics-individuals-25-years-old-or
Counts and Characteristics of Individuals 25 Years Old or Younger With Drug-Device or Biologic-Device Combination Use: A Descriptive Analysis
Analyses
04/18/2022
Analyses
04/18/2022
https://sentinelinitiative.org/methods-data-tools/methods/approaches-handling-partially-observed-confounder-data-electronic-health
Approaches to Handling Partially Observed Confounder Data From Electronic Health Records (EHR) In Non-randomized Studies of Medication Outcomes
Methods, Data, & Tools
06/01/2022
Methods, Data, & Tools
06/01/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/bamlanivimab-bamlanivimab-and-etesevimab-and-casirivimab
Bamlanivimab, Bamlanivimab and Etesevimab, and Casirivimab-Imdevimab Use in Patients with COVID-19: A Descriptive Analysis
Analyses
06/14/2022
Analyses
06/14/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/use-monoclonal-antibodies-mabs-under-emergency-use
Use of Monoclonal Antibodies (mAbs) Under an Emergency Use Authorization (EUA) in Patients with COVID-19 Diagnosis: A Descriptive Analysis
Analyses
06/24/2022
Analyses
06/24/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/hospitalization-and-anaphylaxis-following-monoclonal
Hospitalization and Anaphylaxis Following Monoclonal Antibodies (mAb) Use in Patients with COVID-19: A Descriptive Analysis
Analyses
07/14/2022
Analyses
07/14/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/use-monoclonal-antibodies-mabs-under-emergency-use-0
Use of Monoclonal Antibodies (mAbs) Under an Emergency Use Authorization (EUA) in Patients with COVID-19 Diagnosis: An Updated Descriptive Analysis
Analyses
08/24/2022
Analyses
08/24/2022
https://sentinelinitiative.org/news-events/publications-presentations/impact-nitrosamine-contamination-recalls-angiotensin
Impact of Nitrosamine Contamination Recalls on Angiotensin-Receptor-Blocker (ARB) Utilization in the U.S., U.K., Canada, and Denmark
Publications and Presentations
08/26/2022
Publications and Presentations
08/26/2022
https://sentinelinitiative.org/news-events/publications-presentations/identification-obesity-and-tobacco-use-claims-compared
Identification of Obesity and Tobacco Use in Claims Compared to Electronic Health Record (EHR) Data
Publications and Presentations
08/28/2022
Publications and Presentations
08/28/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-ozempic-use-patients-type-2
Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis
Analyses
11/10/2022
Analyses
11/10/2022
https://sentinelinitiative.org/news-events/publications-presentations/using-food-and-drug-administrations-sentinel-system
Using the Food and Drug Administration's Sentinel System for Surveillance of TB Infection
Publications and Presentations
12/01/2022
Publications and Presentations
12/01/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/congenital-malformations-observed-mother-s-or-linked-infant
Congenital Malformations Observed in the Mother’s or Linked Infant’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis
Analyses
03/03/2023
Analyses
03/03/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/congenital-malformations-observed-mother-s-records-following
Congenital Malformations Observed in the Mother’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis
Analyses
03/03/2023
Analyses
03/03/2023
https://sentinelinitiative.org/news-events/publications-presentations/valsartan-losartan-and-irbesartan-use-usa-uk-canada-and
Valsartan, Losartan and Irbesartan Use in the USA, UK, Canada and Denmark After the Nitrosamine Recalls: A Descriptive Cohort Study
Publications and Presentations
04/17/2023
Publications and Presentations
04/17/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-cannabis-derived-product-users-trinetx-five
Characterization of Cannabis-Derived Product Users in TriNetX: Five Descriptive Analyses
Analyses
07/19/2023
Analyses
07/19/2023
https://sentinelinitiative.org/news-events/publications-presentations/high-dose-dexamethasone-covid-19-not-common-large-us
High Dose Dexamethasone for COVID-19 Not Common in a Large US Hospital Network
Publications and Presentations
08/25/2023
Publications and Presentations
08/25/2023
https://sentinelinitiative.org/news-events/publications-presentations/expanding-capabilities-unapproved-cannabis-derived-product
Expanding Capabilities for Unapproved Cannabis-Derived Product Surveillance in the United States, TriNetX, July 1, 2018 – June 30, 2022
Publications and Presentations
08/27/2023
Publications and Presentations
08/27/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-guselkumab-risankizumab-tildrakizumab-and
Utilization of Guselkumab, Risankizumab, Tildrakizumab, and Brodalumab: Second Descriptive Analysis
Analyses
12/07/2023
Analyses
12/07/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-drug-device-or-biologic-device-combinations
Utilization of Drug-Device or Biologic-Device Combinations: A Descriptive Analysis
Analyses
12/28/2023
Analyses
12/28/2023
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2024-sentinel-innovation-and-methods-seminar-series
2024 Sentinel Innovation and Methods Seminar Series
Sentinel Initiative Events
01/01/2024
Sentinel Initiative Events
01/01/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/medication-use-among-pregnant-individuals-covid-19-0
Medication Use Among Pregnant Individuals With COVID-19: A Descriptive Analysis
Analyses
01/11/2024
Analyses
01/11/2024
https://sentinelinitiative.org/news-events/publications-presentations/validity-inpatient-electronic-health-record-based-measures
Validity of Inpatient Electronic Health Record-Based Measures of Oxygen-Related Therapy in the United States: Lessons Applicable for Studying COVID-19 Endpoints
Publications and Presentations
04/02/2024
Publications and Presentations
04/02/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-loop-diuretics-descriptive-analysis
Utilization of Loop Diuretics: A Descriptive Analysis
Analyses
04/12/2024
Analyses
04/12/2024
https://sentinelinitiative.org/news-events/fda-safety-communications-labeling-changes/fda-labeling-change-vedolizumab-interstitial
FDA Labeling Change: Vedolizumab & Interstitial Lung Disease (ILD)
Regulatory Impact
04/18/2024
Regulatory Impact
04/18/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/concomitant-use-medications-drug-drug-interactions
Concomitant Use of Medications with Drug-Drug Interactions with Nirmatrelvir and Ritonavir Among Patients Treated with Nirmatrelvir and Ritonavir or Patients with COVID-19: A Descriptive Analysis
Analyses
05/17/2024
Analyses
05/17/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/serious-infection-following-ustekinumab-use-patients-crohn-0
Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease: An Inverse Probability of Treatment Weighting Analysis
Analyses
06/24/2024
Analyses
06/24/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-methotrexate-descriptive-analysis-trinetx
Utilization of Methotrexate: A Descriptive Analysis in TriNetX
Analyses
07/17/2024
Analyses
07/17/2024
https://sentinelinitiative.org/news-events/publications-presentations/identifying-pediatric-hypertension-observational-data
Identifying Pediatric Hypertension in Observational Data: Comparing Clinical and Claims Cohorts in Real World Data
Publications and Presentations
07/24/2024
Publications and Presentations
07/24/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/prevalence-selected-conditions-among-individuals
Prevalence of Selected Conditions Among Individuals with Childbearing Potential: A Descriptive Analysis
Analyses
07/26/2024
Analyses
07/26/2024
https://sentinelinitiative.org/studies/drugs/dupixent-dupilumab
Dupixent (Dupilumab) & Signal Identification
Studies
07/31/2024
Studies
07/31/2024
https://sentinelinitiative.org/studies/drugs/pediatric-patients-0
Pediatric Patients & Characterization
Studies
08/06/2024
Studies
08/06/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-adverse-maternal-health-outcomes-among-pregnant
Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis
Analyses
08/07/2024
Analyses
08/07/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/trends-healthcare-utilization-during-covid-19-pandemic
Trends in Healthcare Utilization During the COVID-19 Pandemic: A Propensity Score Matched and Stratified Analysis in Merative™ MarketScan® Research Databases
Analyses
08/21/2024
Analyses
08/21/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/trends-healthcare-utilization-during-covid-19-pandemic-0
Trends in Healthcare Utilization During the COVID-19 Pandemic: A Propensity Score Matched and Stratified Analysis in the Sentinel Distributed Database
Analyses
08/21/2024
Analyses
08/21/2024
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2024-ispe-annual-meeting
2024 ISPE Annual Meeting
Sentinel Initiative Events
08/24/2024
Sentinel Initiative Events
08/24/2024
https://sentinelinitiative.org/news-events/publications-presentations/covid-19-related-changes-healthcare-utilization-among
COVID-19 Related Changes in Healthcare Utilization Among Insured Persons in the U.S. and its Impact on Pharmacoepidemiologic Research
Publications and Presentations
08/26/2024
Publications and Presentations
08/26/2024
https://sentinelinitiative.org/studies/drugs/interrupted-time-series
Interrupted Time Series & Use Case Testing
Studies
08/27/2024
Studies
08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/analysis-medicinal-product-utilization-data-fda-sentinel
Analysis of Medicinal Product Utilization Data in the FDA Sentinel System to Inform the Development of a Pregnancy Safety Study Framework
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/pediatric-utilization-new-molecular-entities-nmes-summary
Pediatric Utilization of New Molecular Entities (NMEs): A Summary of Early Post-Marketing Uptake in the Sentinel Distributed Database
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/prevalence-selected-health-conditions-among-individuals
Prevalence of Selected Health Conditions among Individuals with Childbearing Potential to Inform the Development of the Pregnancy Safety Study Framework
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/patterns-prescribing-and-dispensing-medicines-among-non
Patterns of Prescribing and Dispensing Medicines Among Non-Hospitalized Pregnant Women with COVID-19: a Prospective Meta-Analysis Pooling Findings from Healthcare Databases in Europe and North America
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/prenatal-syphilis-us-characterizing-screening-and-treatment
Prenatal Syphilis in the US: Characterizing Screening and Treatment During Pregnancy in Publicly and Commercially Insured Individuals
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/beta-blocker-associated-hypoglycemia-pediatric-patients
Beta-Blocker-Associated Hypoglycemia in Pediatric Patients: Findings from the FDA Adverse Event Reporting System, National Poison Data System, Medical Literature, and Sentinel Distributed Database
Publications and Presentations
08/28/2024
Publications and Presentations
08/28/2024
https://sentinelinitiative.org/news-events/publications-presentations/comparative-bleeding-risks-among-noac-users-nonvalvular
Comparative Bleeding Risks Among NOAC Users for Nonvalvular Atrial Fibrillation Aged Under 65 years in the Sentinel System
Publications and Presentations
08/28/2024
Publications and Presentations
08/28/2024
https://sentinelinitiative.org/studies/drugs/immunosuppressive-medications
Immunosuppressive Medications & Duration of Follow-Up
Analyses
09/09/2024
Analyses
09/09/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-guselkumab-use-signal
Outcome Monitoring Following Guselkumab Use: A Signal Identification Analysis
Analyses
09/17/2024
Analyses
09/17/2024
https://sentinelinitiative.org/news-events/publications-presentations/exposure-valsartan-products-containing-nitrosamine
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark
Publications and Presentations
09/18/2024
Publications and Presentations
09/18/2024
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/regional-health-information-exchanges-critical-national
Regional Health Information Exchanges as Critical National Infrastructure: Supporting Federal Agency Missions
Sentinel Initiative Events
09/25/2024
Sentinel Initiative Events
09/25/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-risankizumab-use-supplemental
Outcome Monitoring Following Risankizumab Use: A Supplemental Signal Identification Analysis
Analyses
10/01/2024
Analyses
10/01/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-risankizumab-use-signal
Outcome Monitoring Following Risankizumab Use: A Signal Identification Analysis
Analyses
10/01/2024
Analyses
10/01/2024
https://sentinelinitiative.org/news-events/publications-presentations/safety-signal-identification-risankizumab-rzaa-sentinel
Safety Signal Identification for Risankizumab-rzaa in the Sentinel Distributed Database Using Self-Controlled and Active Comparator Study Designs
Publications and Presentations
10/01/2024
Publications and Presentations
10/01/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-products-labeling-changes-related-pregnancy
Utilization of Products with Labeling Changes Related to Pregnancy Among Mothers with Live-Birth Deliveries: A Descriptive Analysis
Analyses
10/02/2024
Analyses
10/02/2024
https://sentinelinitiative.org/news-events/publications-presentations/scalable-incident-detection-natural-language-processing-and
Scalable Incident Detection Via Natural Language Processing and Probabilistic Language Models
Publications and Presentations
10/08/2024
Publications and Presentations
10/08/2024
https://sentinelinitiative.org/news-events/publications-presentations/fda-sentinel-real-world-evidence-data-enterprise-rwe-de
The FDA Sentinel Real World Evidence Data Enterprise (RWE-DE)
Publications and Presentations
10/10/2024
Publications and Presentations
10/10/2024
https://sentinelinitiative.org/news-events/publications-presentations/use-hydrochlorothiazide-united-states-following-label-0
Use of Hydrochlorothiazide in the United States Following Label Update About Skin Cancer Risk
Publications and Presentations
10/13/2024
Publications and Presentations
10/13/2024
https://sentinelinitiative.org/studies/evaluation-confounding-control-estimations-influenza-antivirals-use-and-influenza
Evaluation of Confounding Control in Estimations of Influenza Antivirals Use and Influenza Complications: A Propensity Score Matched Analysis
Modular Programs
10/14/2024
Modular Programs
10/14/2024
https://sentinelinitiative.org/studies/drugs/covid-19
COVID-19 & Venous Thromboembolism (VTE) and Arterial Thromboembolism (ATE)
Studies
10/15/2024
Studies
10/15/2024
https://sentinelinitiative.org/studies/drugs/covid-19-patients
COVID-19 Patients & Long COVID
Studies
10/15/2024
Studies
10/15/2024
https://sentinelinitiative.org/studies/drugs/mixed-amphetamine-salts
Mixed Amphetamine Salts & Switching Patterns
Studies
10/15/2024
Studies
10/15/2024
https://sentinelinitiative.org/studies/drugs/provigil-modafinil-and-nuvigil-armodafinil-0
Provigil (Modafinil) and Nuvigil (Armodafinil) & Congenital Cardiac and Non-Cardiac Malformations
Studies
10/15/2024
Studies
10/15/2024
https://sentinelinitiative.org/studies/drugs/aldactone-spironolactone
Aldactone (spironolactone) & Indications for Use
Studies
10/15/2024
Studies
10/15/2024
https://sentinelinitiative.org/studies/drugs/covid-19-outcomes
COVID-19 Patients & Racial and Ethnic Differences
Studies
10/15/2024
Studies
10/15/2024
https://sentinelinitiative.org/studies/drugs/glomerular-diseases
Glomerular Diseases & Prevalence
Studies
10/15/2024
Studies
10/15/2024
https://sentinelinitiative.org/studies/drugs/women-heart-failure
Women with Heart Failure & Pregnancy
Studies
10/15/2024
Studies
10/15/2024
https://sentinelinitiative.org/studies/drugs/statins-tumor-necrosis-factor-tnf-alpha-inhibitors-granulocyte-colony-stimulating
Statins, Tumor Necrosis Factor (TNF) Alpha Inhibitors, Granulocyte Colony Stimulating Factors, Intravenous (IV) Iron, Beta Blockers, and Angiotensin-Converting Enzyme (ACE) Inhibitors & Utilization
Studies
10/15/2024
Studies
10/15/2024
https://sentinelinitiative.org/studies/drugs/enterovirus
Enterovirus & Neonatal Enteroviral Sepsis
Studies
10/15/2024
Studies
10/15/2024
https://sentinelinitiative.org/studies/drugs/hydroxyurea
Hydroxyurea & Use by Indication
Studies
10/15/2024
Studies
10/15/2024
https://sentinelinitiative.org/studies/drugs/brintellix-vortioxetine-and-brilinta-ticragelor
Brintellix (Vortioxetine) and Brilinta (Ticragelor) & Medication Errors
Studies
10/15/2024
Studies
10/15/2024
https://sentinelinitiative.org/studies/drugs/drugs-risk-evaluation-and-mitigation-strategies-rems-employ-elements-assure-safe-use
Drugs with Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU) & Utilization
Studies
10/16/2024
Studies
10/16/2024
https://sentinelinitiative.org/news-events/publications-presentations/pediatric-utilization-new-molecular-entities-nmes-summary-0
Pediatric Utilization of New Molecular Entities (NMEs): A Summary of Early Post-marketing Uptake in the Sentinel Distributed Database
Publications and Presentations
10/16/2024
Publications and Presentations
10/16/2024
https://sentinelinitiative.org/studies/drugs/olumiant-baricitinib-and-actemra-tocilizumab
Olumiant (Baricitinib) and Actemra (Tocilizumab) & Emergency Use Authorization (EUA) Utilization
Studies
10/16/2024
Studies
10/16/2024
https://sentinelinitiative.org/studies/drugs/latent-tuberculosis-infection
Latent Tuberculosis Infection & Surveillance
Studies
10/16/2024
Studies
10/16/2024
https://sentinelinitiative.org/news-events/publications-presentations/dexamethasone-dose-covid-19-large-us-hospital-network-april
Dexamethasone Dose for COVID-19 in a Large U.S. Hospital Network From April 2020 to May 2023
Publications and Presentations
10/17/2024
Publications and Presentations
10/17/2024
https://sentinelinitiative.org/news-events/publications-presentations/analyzing-missingness-patterns-real-world-data-using-smdi
Analyzing Missingness Patterns in Real-World Data Using the SMDI Toolkit: Application to a Linked EHR-Claims Pharmacoepidemiology Study
Publications and Presentations
10/19/2024
Publications and Presentations
10/19/2024
https://sentinelinitiative.org/news-events/publications-presentations/assessing-harmonization-structured-electronic-health-record
Assessing the Harmonization of Structured Electronic Health Record Data to Reference Terminologies and Data Completeness Through Data Provenance
Publications and Presentations
10/21/2024
Publications and Presentations
10/21/2024
https://sentinelinitiative.org/studies/drugs/local-anesthetics
Local Anesthetics & Anesthetic Toxicity
Studies
10/23/2024
Studies
10/23/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/counts-and-characteristics-local-anesthetic-toxicity
Counts and Characteristics of Local Anesthetic Toxicity
Analyses
10/23/2024
Analyses
10/23/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/prevalence-selected-conditions-among-individuals-0
Prevalence of Selected Conditions Among Individuals with Childbearing Potential: A Second Descriptive Analysis
Analyses
10/25/2024
Analyses
10/25/2024
https://sentinelinitiative.org/studies/drugs/trends-healthcare-utilization-during-covid-19-pandemic
Trends in Healthcare Utilization During the COVID-19 Pandemic
Studies
10/25/2024
Studies
10/25/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-methotrexate-descriptive-analysis
Utilization of Methotrexate: A Descriptive Analysis
Modular Programs
10/28/2024
Modular Programs
10/28/2024
https://sentinelinitiative.org/news-events/publications-presentations/lyme-disease-prophylaxis-single-dose-doxycycline-united
Lyme Disease Prophylaxis by Single-Dose Doxycycline in the United States, 2010–2020
Publications and Presentations
10/29/2024
Publications and Presentations
10/29/2024
https://sentinelinitiative.org/news-events/fda-advisory-committee-meetings/meeting-endocrinologic-and-metabolic-drugs-advisory-1
Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee Meeting: Sotagliflozin and Diabetic Ketoacidosis (October 31, 2024)
Regulatory Impact
10/31/2024
Regulatory Impact
10/31/2024
https://sentinelinitiative.org/news-events/publications-presentations/letter-editor-considerations-regarding-association
Letter to the Editor: Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy
Publications and Presentations
10/31/2024
Publications and Presentations
10/31/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-guselkumab-use-signal-0
Outcome Monitoring Following Guselkumab Use: A Signal Identification and Self-Controlled Risk Interval Analysis
Analyses
11/01/2024
Analyses
11/01/2024
https://sentinelinitiative.org/studies/drugs/tremfya-guselkumab-0
Tremfya (Guselkumab) & Signal Identification
Studies
11/01/2024
Studies
11/01/2024
https://sentinelinitiative.org/studies/drugs/hydrochlorothiazide-1
Hydrochlorothiazide & Utilization
Studies
11/01/2024
Studies
11/01/2024
https://sentinelinitiative.org/studies/drugs/gilenya-fingolimod
Gilenya (Fingolimod) & Congenital Cardiac Malformations, Congenital Urinary Malformations, and All Congenital Malformations
Studies
11/04/2024
Studies
11/04/2024
https://sentinelinitiative.org/studies/drugs/cannabis
Cannabis & Substance Use Disorder and Poisoning
Studies
11/06/2024
Studies
11/06/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characteristics-patients-healthcare-encounters-involving
Characteristics of Patients with Healthcare Encounters Involving Disorders or Poisoning Related to Cannabis, Cocaine, Alcohol, Heroin, or Benzodiazepines: A Descriptive Analysis
Analyses
11/06/2024
Analyses
11/06/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characteristics-patients-healthcare-encounters-involving-0
Characteristics of Patients with Healthcare Encounters Involving Disorders or Poisoning Related to Cannabis: A Descriptive Analysis
Analyses
11/06/2024
Analyses
11/06/2024
https://sentinelinitiative.org/studies/drugs/entyvio-vedolizumab-and-tysabri-natalizumab
Entyvio (Vedolizumab) and Tysabri (Natalizumab) & Interstitial Lung Disease
Studies
11/06/2024
Studies
11/06/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/trends-healthcare-encounters-involving-disorders-or
Trends in Healthcare Encounters Involving Disorders or Poisoning Related to Cannabis, Stratified by the Legality Status of Cannabis by State and Territory: A Descriptive Analysis
Analyses
11/06/2024
Analyses
11/06/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/trends-healthcare-encounters-evidence-disorders-related-use
Trends in Healthcare Encounters with Evidence of Disorders Related to the Use, Abuse, or Dependence of Cannabis, Cocaine, or Alcohol: A Descriptive Analysis
Analyses
11/06/2024
Analyses
11/06/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/trends-healthcare-encounters-evidence-poisoning-cannabis
Trends in Healthcare Encounters with Evidence of Poisoning by Cannabis, Cocaine, Alcohol, Heroin, or Benzodiazepines: A Descriptive Analysis
Analyses
11/06/2024
Analyses
11/06/2024
https://sentinelinitiative.org/studies/drugs/proton-pump-inhibitors
Proton Pump Inhibitors & COVID-19 Hospitalization and Severe COVID-19
Studies
11/06/2024
Studies
11/06/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/trends-single-dose-doxycycline-lyme-disease-prophylaxis
Trends in Single-Dose Doxycycline for Lyme Disease Prophylaxis in the United States: An Updated Descriptive Analysis
Analyses
11/06/2024
Analyses
11/06/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/trends-single-dose-doxycycline-lyme-disease-prophylaxis-0
Trends in Single-Dose Doxycycline for Lyme Disease Prophylaxis in the United States: A Descriptive Analysis
Analyses
11/06/2024
Analyses
11/06/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-users-atogepant-trinetx-descriptive
Characterization of Users of Atogepant in TriNetX: A Descriptive Analysis
Modular Programs
11/06/2024
Modular Programs
11/06/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-proton-pump-inhibitors-ppis-single-agent-h2
Utilization of Proton Pump Inhibitors (PPIs), Single-Agent H2 Receptor Antagonists (H2RAs), and Famotidine in Patients with Gastroesophageal Reflux Disease (GERD): A Descriptive Analysis
Analyses
11/06/2024
Analyses
11/06/2024
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2024-16th-annual-sentinel-initiative-public-workshop
2024 16th Annual Sentinel Initiative Public Workshop
Sentinel Initiative Events
11/07/2024
Sentinel Initiative Events
11/07/2024
https://sentinelinitiative.org/studies/drugs/skyrizi-risankizumab-rzaa
Skyrizi (Risankizumab-Rzaa) & Signal Identification
Studies
11/07/2024
Studies
11/07/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-risankizumab-and-comparator-products-descriptive
Utilization of Risankizumab and Comparator Products: A Descriptive Analysis
Modular Programs
11/07/2024
Modular Programs
11/07/2024
https://sentinelinitiative.org/studies/drugs/covid-19-emergency-use-authorization-eua-drugs
COVID-19 Emergency Use Authorization (EUA) Drugs & Utilization, Anaphylaxis, and Hospitalization
Studies
11/12/2024
Studies
11/12/2024
https://sentinelinitiative.org/news-events/publications-presentations/data-driven-automated-classification-algorithms-acute-1
Data-Driven Automated Classification Algorithms for Acute Health Conditions: Applying PheNorm to Anaphylaxis
Publications and Presentations
11/12/2024
Publications and Presentations
11/12/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-valsartan-descriptive-analysis
Utilization of Valsartan: A Descriptive Analysis
Analyses
11/12/2024
Analyses
11/12/2024
https://sentinelinitiative.org/news-events/publications-presentations/enhancing-causes-death-prediction-electronic-health-records
Enhancing Causes of Death Prediction from Electronic Health Records through Multi-Modal Integration of Structured and Unstructured EHR Data
Publications and Presentations
11/13/2024
Publications and Presentations
11/13/2024
https://sentinelinitiative.org/studies/drugs/bumex-bumetanide
Bumex (Bumetanide) & Nitrosamine Impurity
Studies
11/14/2024
Studies
11/14/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/cancer-rates-among-individuals-loop-diuretics-exposure
Cancer Rates Among Individuals with Loop Diuretics Exposure: A Descriptive Analysis
Analyses
11/14/2024
Analyses
11/14/2024
https://sentinelinitiative.org/studies/drugs/her2-antagonists
HER2 Antagonists & Use in Pregnancy
Studies
11/14/2024
Studies
11/14/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/rates-nervous-system-disorders-following-bortezomib-use
Rates of Nervous System Disorders Following Bortezomib Use in Patients: A Descriptive Analysis
Analyses
11/18/2024
Analyses
11/18/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/adherence-absolute-neutrophil-count-anc-monitoring
Adherence to Absolute Neutrophil Count (ANC) Monitoring Recommendations Following Clozapine Use: First Descriptive Analysis
Analyses
11/19/2024
Analyses
11/19/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/adherence-absolute-neutrophil-count-anc-monitoring-0
Adherence to Absolute Neutrophil Count (ANC) Monitoring Recommendations Following Clozapine Use: Second Descriptive Analysis
Analyses
11/19/2024
Analyses
11/19/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/adherence-absolute-neutrophil-count-anc-monitoring-1
Adherence to Absolute Neutrophil Count (ANC) Monitoring Recommendations Following Clozapine Use: Third Descriptive Analysis
Analyses
11/19/2024
Analyses
11/19/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/clozapine-use-first-descriptive-analysis
Clozapine Use: First Descriptive Analysis
Analyses
11/19/2024
Analyses
11/19/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/clozapine-use-second-descriptive-analysis
Clozapine Use: Second Descriptive Analysis
Analyses
11/19/2024
Analyses
11/19/2024
https://sentinelinitiative.org/news-events/fda-advisory-committee-meetings/joint-meeting-drug-safety-and-risk-management-1
Joint Meeting of the Drug Safety and Risk Management Advisory Committee and Psychopharmacologic Drugs Advisory Committee Meeting
Regulatory Impact
11/19/2024
Regulatory Impact
11/19/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-guselkumab-risankizumab-tildrakizumab-and-0
Utilization of Guselkumab, Risankizumab, Tildrakizumab, and Brodalumab: Third Descriptive Analysis
Analyses
11/19/2024
Analyses
11/19/2024
https://sentinelinitiative.org/studies/drugs/individuals-childbearing-potential
Individuals with Childbearing Potential & Conditions Prevalence
Studies
11/21/2024
Studies
11/21/2024
https://sentinelinitiative.org/studies/drugs/new-molecular-entities-nmes
New Molecular Entities (NMEs) & Utilization Characterization
Studies
11/27/2024
Studies
11/27/2024
https://sentinelinitiative.org/studies/drugs/sodium-glucose-co-transporter-2-sglt2-inhibitors-0
Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors & Cohort Characterization
Studies
11/27/2024
Studies
11/27/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-users-inclisiran-trinetx-descriptive
Characterization of Users of Inclisiran in TriNetX: A Descriptive Analysis
Analyses
11/27/2024
Analyses
11/27/2024
https://sentinelinitiative.org/studies/drugs/cannabinoid-products
Cannabinoid Products & Cohort Characterization
Studies
12/03/2024
Studies
12/03/2024
https://sentinelinitiative.org/studies/drugs/clozapine
Clozapine & Adherence to Absolute Neutrophil Count (ANC) Monitoring and Neutropenia
Studies
12/03/2024
Studies
12/03/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/occurrence-absolute-neutrophil-count-anc-monitoring-and
Occurrence of Absolute Neutrophil Count (ANC) Monitoring and Neutropenia Following Clozapine Use in Patients from Sentinel Data Partners that Curate ANC Laboratory Results: A Descriptive Analysis
Analyses
12/03/2024
Analyses
12/03/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/occurrence-absolute-neutrophil-count-anc-monitoring-anc-laboratory-results-and-neutropenia
Occurrence of Absolute Neutrophil Count (ANC) Monitoring, ANC Laboratory Results, and Neutropenia Following Clozapine Use: A Descriptive Analysis
Analyses
12/03/2024
Analyses
12/03/2024
https://sentinelinitiative.org/studies/drugs/corticosteroids-inpatient-utilization
Corticosteroids & Inpatient Utilization
Studies
12/03/2024
Studies
12/03/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/corticosteroid-utilization-patterns-hospitalized-patients
Corticosteroid Utilization Patterns in Hospitalized Patients With and Without a COVID-19 Diagnosis in TriNetX: A Descriptive Analysis
Analyses
12/03/2024
Analyses
12/03/2024
https://sentinelinitiative.org/studies/drugs/pediatric-patients
Pediatric Patients & Hypertension
Studies
12/04/2024
Studies
12/04/2024
https://sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system
Sentinel Routine Querying System
Methods, Data, & Tools
12/04/2024
Methods, Data, & Tools
12/04/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-severe-hyperglycemia-following-systemic-corticosteroids
Risk of Severe Hyperglycemia Following Systemic Corticosteroids and Azithromycin Use in COVID-19 Patients with Type 2 Diabetes: A Sequential Surveillance Analysis
Analyses
12/04/2024
Analyses
12/04/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-hormonal-contraceptives-following-live-birth-or
Utilization of Hormonal Contraceptives Following Live-Birth or Stillbirth Delivery: A Descriptive Analysis
Analyses
12/10/2024
Analyses
12/10/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/clinical-characteristics-incident-users-glucagon-peptide-1
Clinical Characteristics of Incident Users of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) in TriNetX: A Descriptive Analysis
Analyses
12/11/2024
Analyses
12/11/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/demographic-characteristics-incident-users-selected-non
Demographic Characteristics of Incident Users of Selected Non-Insulin Antidiabetics in TriNetX: A Descriptive Analysis
Analyses
12/11/2024
Analyses
12/11/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-selected-non-insulin-antidiabetics-trinetx
Utilization of Selected Non-Insulin Antidiabetics in TriNetX: A Descriptive Analysis
Analyses
12/11/2024
Analyses
12/11/2024
https://sentinelinitiative.org/methods-data-tools/methods/evaluate-use-dance-algorithm-find-disconnected-negative-controls-and
Evaluate the Use of the DANCE Algorithm to Find Disconnected Negative Controls and Develop a Toolkit
Methods, Data, & Tools
12/18/2024
Methods, Data, & Tools
12/18/2024
https://sentinelinitiative.org/methods-data-tools/software-packages-toolkits/centers-medicare-and-medicaid-services-cms-medicaid
The Centers for Medicare and Medicaid Services (CMS): Medicaid and Children’s Health Insurance Program (CHIP) Claims in Sentinel Common Data Model (SCDM) Format
Methods, Data, & Tools
12/18/2024
Methods, Data, & Tools
12/18/2024
https://sentinelinitiative.org/studies/drugs/rinvoq-upadacitinib
Rinvoq (Upadacitinib) & Acute Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism, and Thrombotic Stroke
Studies
12/20/2024
Studies
12/20/2024
https://sentinelinitiative.org/studies/drugs/olumiant-baricitinib
Olumiant (Baricitinib) & Acute Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism, and Stroke
Studies
12/20/2024
Studies
12/20/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-dispensing-patterns-baricitinib
Characterization of Dispensing Patterns of Baricitinib, Ritlecitinib, and Upadacitinib in Patients with Alopecia, Crohn's Disease, Ulcerative Colitis, and Inflammatory Bowel Disease: A Descriptive Analysis
Analyses
12/20/2024
Analyses
12/20/2024
https://sentinelinitiative.org/studies/drugs/litfulo-ritlecitinib
Litfulo (Ritlecitinib) & Acute Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism & Stroke
Studies
12/20/2024
Studies
12/20/2024